All

Results: 34849-34860 of 74597

PR Newswire associated0

Lockton launches Professional and Executive Risk, transforming its global financial lines business

PR Newswire associated0

Rockwell Automation Revolutionizes Motor Controls with Smarter and Safer M100 Electronic Motor Starter

Business Wire logo

ABEC Unveils Breakthrough Single Use Bioreactor Technology for Cell Therapy Manufacturing

David Ferrando, Ferrer's Chief Marketing and Market Access Officer and Jorge Cuneo, Ferrer's Chief Medical Officer, at the IMPAHCT opening session.

Experts Set International and Multidisciplinary Collaboration As Priorities in Pulmonary Hypertension Management

PR Newswire associated1

Neutrogena® and John Cena Team Up for the Ultimate Disappearing Act in New Ultra Sheer ® Mineral Sunscreen Campaign

Business Wire logo

ROYC and BCG: Capturing Wealth Management’s $3 Trillion Private Market Opportunity

PR Newswire associated0

HAS Healthcare Advanced Synthesis SA acquires Cerbios-Pharma SA to create leading international Group in the CDMO sector, backed by 65 Equity Partners

Business Wire logo

ICON plc Schedules First Quarter 2025 Earnings Conference Call

Zapp EV Appoints Its First Authorised Reseller in Europe

Birmingham Data Centre

Pulsant to Acquire Two Data Centres From SCC

In 2008, GN Corp initiated research with NCRM, Chennai, Tamil Nadu, India on restoring corneal blindness using buccal tissue epithelial cells. An out of the box idea of Dr. Suryaprakash, Urologist from Hyderabad, India in 2012 to apply buccal (oral) mucosal cells to repair stricture-inflicted male urethra, led to a clinical study, which he presented in NCRM NICHE 2017 in Tokyo, kickstarting a collaboration with Dr. Akio Horiguchi, National Defence Medical College, Japan, as they met in EAU in 2018 (Top right picture). Upon confirming successful cell engraftment in urethral stricture pre-clinical models taking help from the Dept. of Medical Engineering of NDMC between 2018~2023, (Bottom, right picture), now in 2025, clinical application has been initiated in Edogawa Hospital, Tokyo. Main picture: BEES-HAUS team after the first clinical transplant in Edogawa Hospital, Tokyo; Dr.Horiguchi (Centre) with Dr.Shojiro Katoh (President, Edogawa Hospital) standing left to him.

Cell therapy for male urethral stricture: BEES-HAUS clinical application in Edogawa Hospital Japan, reports Dr. Akio Horiguchi in IMORU.

Business Wire logo

BeiGene Receives Positive CHMP Opinion for TEVIMBRA® as a First-Line Treatment for Extensive-Stage Small Cell Lung Cancer